z-logo
open-access-imgOpen Access
Benefit of Monascus-fermented products for hypertension prevention: a review
Author(s) -
BaoHong Lee,
TzuMing Pan
Publication year - 2012
Publication title -
applied microbiology and biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.074
H-Index - 221
eISSN - 1432-0614
pISSN - 0175-7598
DOI - 10.1007/s00253-012-4076-2
Subject(s) - monascus , fermentation , nutraceutical , pharmacology , disease , diabetes mellitus , health benefits , medicine , biology , chemistry , biochemistry , traditional medicine , endocrinology
γ-Aminobutyric acid (GABA) has been reported to play a neurotransmitter in the central nervous system thereby exerting an inhibition in nerve impulse, in turn ameliorating depression; in addition, recent study also reveals the anti-hypertensive effect of GABA in vivo. Edible fungi of the Monascus species have been used as traditional Chinese medicine in eastern Asia for several centuries. Monascus-fermented products possess a number of functional secondary metabolites, including anti-inflammatory pigments (such as monascin and ankaflavin), monacolins, dimerumic acid, and GABA. Several scientific studies have shown that these secondary metabolites have anti-inflammatory, anti-oxidative, and anti-tumor activities. Moreover, many published reports have shown the efficacy of Monascus-fermented products in the prevention or amelioration of some diseases, including hypercholesterolemia, hyperlipidemia, hypertension, diabetes, obesity, Alzheimer's disease, and numerous types of cancer in recent studies. The current article discusses and provides evidence to elucidate the anti-hypertensive benefit of Monascus-fermented metabolites, including anti-inflammatory pigments and GABA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom